Acadia Pharms Inc
1 products tracked · names used in filings: Acadia Pharms Inc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Thu 11 Dec 2025🇺🇸 FDA approval
FDA approves Daybue Stix (trofinetide): new dosage form
Acadia Pharms Inc; NDA219884; New dosage form; for solution, solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Daybue Stix trofinetide | Approved | 2025-12-11 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.